Maternal Immune Activation in a Genetic Mouse Model of ASD
ASD 遗传小鼠模型中的母体免疫激活
基本信息
- 批准号:9117628
- 负责人:
- 金额:$ 37.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnti-Inflammatory AgentsAnti-inflammatoryBehaviorBehavioralBrainDendritic SpinesDevelopmentDiseaseElectrophysiology (science)Environmental Risk FactorEpidemiologic StudiesEtiologyExhibitsExposure toGene ExpressionGenesGeneticGenetic RiskHealthImage AnalysisImmuneImmune System and Related DisordersImpairmentInfectionLeadMediatingMolecularMusMutant Strains MiceMutationPathway interactionsPregnancyProteinsRegulationRett SyndromeRiskRisk FactorsSynapsesTestingUp-RegulationWhole-Cell Recordingsautism spectrum disorderbehavioral impairmentbrain pathwaydisorder riskgenetic risk factorimmune activationin vivo imaginginsightmouse modelmutantneurobehavioralneuropathologynoveloffspringpostnatalprenatal exposurepreventrisk variant
项目摘要
DESCRIPTION (provided by applicant): Autism spectrum disorder (ASD) is a diverse disorder that is likely to be caused by a combination of genetic alterations and environmental insult during early development. Studies demonstrate an association between maternal immune activation (MIA) during pregnancy and an increased risk for ASD. Recent development of mouse models for prenatal exposure to maternal immune activation (MIA) show that the challenged offspring demonstrate impaired behaviors relevant to ASD as well as exhibit altered levels of immune proteins. A significant gap exists in understanding how altered immune state interacts with ASD risk genes to result in impaired behaviors. Here we will test the hypothesis altered regulation of MHC1 proteins is a mechanism of convergence for MIA and ASD genetic risk factors. Specifically, we will examine how mutations in mecp2, a gene responsible for the Rett syndrome and also associated with non-Rett ASD cases, interact with MIA. We will, combine behavioral, molecular, electrophysiological and synaptic in vivo imaging analyses in relevant brain circuits to determine how altered Mecp2 levels and MIA converge to results in altered behavior and neuropathology.
描述(由申请人提供):自闭症谱系障碍(ASD)是一种多样的疾病,可能是由遗传改变和早期发育过程中的环境损伤引起的。研究表明,怀孕期间母体免疫激活(MIA)与ASD风险增加之间存在关联。最近开发的产前暴露于母体免疫激活(MIA)的小鼠模型显示,受到挑战的后代表现出与ASD相关的受损行为,以及表现出免疫蛋白水平的改变。在理解改变的免疫状态如何与ASD风险基因相互作用以导致行为受损方面存在重大差距。在这里,我们将测试的假设改变调节MHC1蛋白是一种机制的收敛MIA和ASD遗传风险因素。具体来说,我们将研究mecp2(一种负责Rett综合征的基因,也与非Rett ASD病例相关)的突变如何与MIA相互作用。我们将结合联合收割机在相关脑回路中的行为、分子、电生理和突触体内成像分析,以确定改变的Mecp 2水平和MIA如何会聚以导致改变的行为和神经病理学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anna Dunaevsky其他文献
Anna Dunaevsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anna Dunaevsky', 18)}}的其他基金
Translational Imaging and Behavioral Assessment (TIBA) Core
转化成像和行为评估 (TIBA) 核心
- 批准号:
10603354 - 财政年份:2022
- 资助金额:
$ 37.53万 - 项目类别:
Developing an Astroglial Model for Fragile X Syndrome
开发脆性 X 综合征的星形胶质细胞模型
- 批准号:
10317618 - 财政年份:2021
- 资助金额:
$ 37.53万 - 项目类别:
Cognitive Neuroscience of Development and Aging (CoNDA) Center Supplement
发育与衰老认知神经科学 (CoNDA) 中心增刊
- 批准号:
10400412 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
Cognitive Neuroscience of Development and Aging (CONDA) Center
发育与衰老认知神经科学 (CONDA) 中心
- 批准号:
10597970 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
Training, Evaluation, Engagement, Administration, and Mentoring (TEEAM) Core
培训、评估、参与、管理和指导 (TEEAM) 核心
- 批准号:
10360488 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
Training, Evaluation, Engagement, Administration, and Mentoring (TEEAM) Core
培训、评估、参与、管理和指导 (TEEAM) 核心
- 批准号:
10894437 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
Training, Evaluation, Engagement, Administration, and Mentoring (TEEAM) Core
培训、评估、参与、管理和指导 (TEEAM) 核心
- 批准号:
10597971 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
Cognitive Neuroscience of Development and Aging (CONDA) Center
发育与衰老认知神经科学 (CONDA) 中心
- 批准号:
10360484 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
Translational Imaging and Behavioral Assessment (TIBA) Core
转化成像和行为评估 (TIBA) 核心
- 批准号:
10654518 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
Cognitive Neuroscience of Development and Aging (CONDA) Center
发育与衰老认知神经科学 (CONDA) 中心
- 批准号:
10854463 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 37.53万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 37.53万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 37.53万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 37.53万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 37.53万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 37.53万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 37.53万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 37.53万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 37.53万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 37.53万 - 项目类别: